(Albany, US) DelveInsight has launched a new report on “Alopecia Pipeline Insight, 2020”.
“Alopecia Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Alopecia market. A detailed picture of the Alopecia pipeline landscape is provided, which includes the disease overview and Alopecia treatment guidelines.
The assessment part of the report embraces in-depth Alopecia commercial assessment and clinical assessment of the Alopecia pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Alopecia collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
Some of key companies are-
Request for free sample report: https://www.delveinsight.com/sample-request/alopecia-pipeline-insight
Name of drugs covered which are given below-
Scope of the Report
Hair loss also known as alopecia or baldness, refers to a loss of hair from part of the head or body. Typically, at least the head is involved, and the severity of hair loss can vary from a small area to the entire body.
About one-third of women experience hair loss at some time in their lives; among postmenopausal women, as many as two-thirds suffer hair thinning or bald spots. Hair loss in women often has a greater impact than hair loss does on men, because it is less socially acceptable for them. Alopecia can severely affect a woman’s emotional well-being and quality of life.
The condition occurs when white blood cells attack the cells in hair follicles, causing them to shrink and dramatically slow down hair production. It is unknown precisely what causes the body’s immune system to target hair follicles in this way.
There are different types of alopecia varying in terms of causes, severity (how much hair falls out), patterns of hair loss, the usual age it starts and body parts affected. Most of the people have alopecia areata, which is often used as an umbrella name for a spectrum (a range) of types: areata, totalis, and universalis. Because alopecia areata is a spectrum, many people had hair loss ‘in-between’ these named points. Some people found that their alopecia changed along the spectrum over time.
The extreme forms of alopecia areata are alopecia total is, which involves the loss of all head hair, and alopecia universal is, which involves the loss of all hair from the head and the body.
The main type of hair loss in women is the same as it is men.
It is called androgenetic alopecia (AGA), or female (or male) pattern hair loss. In men, hair loss usually begins above the temples, and the receding hairline eventually forms a characteristic “M” shape; hair at the top of the head also thins, often progressing to baldness. In women, androgenetic alopecia begins with gradual thinning at the part line, followed by increasing diffuse hair loss radiating from the top of the head. A woman’s hairline rarely recedes, and women rarely become bald.
Dihydrotestosterone (DHT) is the main hormone responsible for Androgenetic Alopecia in genetically susceptible individuals. DHT causes hair loss by inducing a change in the hair follicles. The hairs produced by the follicles affected by DHT become progressively smaller until eventually the follicles shrink completely and stop producing hair entirely.
Table of Contents:
1. Report Introduction
2. Alopecia
2.1. Overview
2.2. History
2.3. Alopecia Symptoms
2.4. Causes
2.5.Pathophysiology
2.6. Alopecia Diagnosis
2.6.1. Diagnostic Guidelines
3. Alopecia Current Treatment Patterns
3.1. Alopecia Treatment Guidelines
4. Alopecia – DelveInsight’s Analytical Perspective
4.1. In-depth Commercial Assessment
4.1.1. Alopecia companies collaborations, Licensing, Acquisition -Deal Value Trends
4.1.1.1. Assessment Summary
4.1.2. Alopecia Collaboration Deals
4.1.2.1. Company-Company Collaborations (Licensing / Partnering) Analysis
4.1.2.2. Company-University Collaborations (Licensing / Partnering) Analysis
4.1.2.3. Alopecia Acquisition Analysis
5. Therapeutic Assessment
5.1. Clinical Assessment of Pipeline Drugs
5.1.1. Assessment by Phase of Development
5.1.2. Assessment by Product Type (Mono / Combination)
5.1.2.1. Assessment by Stage and Product Type
5.1.3. Assessment by Route of Administration
5.1.3.1. Assessment by Stage and Route of Administration
5.1.4. Assessment by Molecule Type
5.1.4.1. Assessment by Stage and Molecule Type
5.1.5. Assessment by MOA
5.1.5.1. Assessment by Stage and MOA
5.1.6. Assessment by Target
5.1.6.1. Assessment by Stage and Target
6. Alopecia Late Stage Products (Phase-III)
7. Alopecia Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Alopecia Discontinued Products
13. Alopecia Product Profiles
13.1. Drug Name: Company
13.1.1. Product Description
13.1.1.1. Product Overview
13.1.1.2. Mechanism of action
13.1.2. Research and Development
13.1.2.1. Clinical Studies
13.1.3. Product Development Activities
13.1.3.1. Collaboration
13.1.3.2. Agreements
13.1.3.3. Acquisition
13.1.3.4. Patent Detail
13.1.4. Tabulated Product Summary
13.1.4.1. General Description Table
Detailed information in the report?
14. Alopecia Key Companies
15. Alopecia Key Products
16. Dormant and Discontinued Products
16.1. Dormant Products
16.1.1. Reasons for being dormant
16.2. Discontinued Products
16.2.1. Reasons for the discontinuation
17. Alopecia Unmet Needs
18. Alopecia Future Perspectives
19. Alopecia Analyst Review
20. Appendix
21. Report Methodology
21.1. Secondary Research
21.2. Expert Panel Validation
Request for Detailed TOC: https://www.delveinsight.com/sample-request/alopecia-pipeline-insight
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/sample-request/alopecia-pipeline-insight